Christian Gyllenberg - Neola Medical Chief Officer
NEOLA Stock | 2.40 0.32 11.76% |
Insider
Christian Gyllenberg is Chief Officer of Neola Medical AB
Web | https://gasporox.se/medical-diagnostics/ |
Similar Executives
Showing other executives | INSIDER Age | ||
Martin Dahlgren | eEducation Albert AB | 30 | |
Anders Holmberg | IAR Systems Group | 56 | |
Jesper Rydaker | IAR Systems Group | 53 | |
Alf Ekstrm | KABE Group AB | 67 | |
Petter Edman | IAR Systems Group | 59 | |
Pascal Nicodeme | Africa Oil Corp | N/A | |
Sebastian Christ | eEducation Albert AB | 38 | |
Stefania Mandirola | AAC Clyde Space | N/A | |
Marina Norberg | Lipum AB | 59 | |
Craig Knight | Africa Oil Corp | N/A | |
Kulwinder Bhumbra | AAC Clyde Space | N/A | |
Paul Martinez | Africa Oil Corp | N/A | |
Robert Hrd | Mekonomen AB | 57 | |
Pernilla Abrahamsson | Lipum AB | 51 | |
Arta Mandegari | eEducation Albert AB | 37 | |
Andrew Strain | AAC Clyde Space | 42 | |
Ehsan Yazdani | eEducation Albert AB | 41 | |
Kylie Litchfield | Africa Oil Corp | N/A | |
Luis Gomes | AAC Clyde Space | 52 | |
Fredrik Satterstrom | Mekonomen AB | N/A | |
Richard Lind | IAR Systems Group | 59 |
Management Performance
Return On Equity | -0.23 | |||
Return On Asset | -0.12 |
Neola Medical AB Leadership Team
Elected by the shareholders, the Neola Medical's board of directors comprises two types of representatives: Neola Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neola. The board's role is to monitor Neola Medical's management team and ensure that shareholders' interests are well served. Neola Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neola Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hanna Sjostrom, CEO MD | ||
Christian Gyllenberg, Chief Officer |
Neola Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Neola Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.23 | |||
Return On Asset | -0.12 | |||
Profit Margin | (0.82) % | |||
Operating Margin | (0.82) % | |||
Current Valuation | 69.42 M | |||
Shares Outstanding | 55.69 M | |||
Shares Owned By Insiders | 72.57 % | |||
Shares Owned By Institutions | 4.33 % | |||
Price To Book | 2.33 X | |||
Price To Sales | 7.03 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Neola Stock Analysis
When running Neola Medical's price analysis, check to measure Neola Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neola Medical is operating at the current time. Most of Neola Medical's value examination focuses on studying past and present price action to predict the probability of Neola Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neola Medical's price. Additionally, you may evaluate how the addition of Neola Medical to your portfolios can decrease your overall portfolio volatility.